Morphogenetic signaling from the cell surface to the nucleus during vertebrate eye development

NIH RePORTER · NIH · R01 · $714,141 · view on reporter.nih.gov ↗

Abstract

Hedgehog Signal Transduction from the Cell Surface to the Nucleus during Vertebrate Eye Development The Hedgehog (Hh) pathway is essential for eye development, controlling a diverse array of fundamental patterning, morphogenesis, and differentiation events during oculogenesis. Misregulated Hh signaling instigates a spectrum of human developmental eye disorders, including holoprosencephaly, cyclopia, uveal coloboma and retinal dystrophy. This signaling pathway is therefore a prime therapeutic target for eye development disorders and for regenerative medicine efforts. During Hh signal transduction, the cell surface atypical G protein-coupled receptor (GPCR) SMOOTHENED (SMO) communicates with GLI transcription factors in the nucleus, via a mechanism that has remained enigmatic for decades. We recently found that SMO directly binds to the catalytic subunit of protein kinase A (PKAcat) and physically blocks its enzymatic activity. As a result, PKAcat cannot phosphorylate and inhibit GLI, leading to GLI activation. Thus, our work highlights two potential routes – traditional G protein coupling and our new direct PKAcat inhibition pathway – for Hh signal transduction from the cell surface to the nucleus during oculogenesis. How these two pathways regulate different stages of eye development, and how to target each of them optimally for therapeutic purposes, remains largely unknown. We hypothesize that SMO controls eye development by deploying the G protein coupling and PKA-binding pathways in a spatiotemporally distinct manner. Here we propose to combine organoid, and animal models, along with protein structure approaches, to uncover how SMO orchestrates eye development. We will: (1) learn how the SMO G protein coupling and PKA-binding pathways controls retinal development, using human retinal organoid development and retinal ganglion cell (RGC) differentiation as outputs for Hh pathway-dependent signaling processes in the human retina; (2) assess the impact of each SMO-dependent pathway on ocular Hh signaling in a whole animal context, using zebrafish to define the spatiotemporal contributions of each SMO-dependent pathway to optic fissure formation and RGC differentiation in vivo; (3) solve the structure of a vertebrate SMO / PKAcat complex using X-ray crystallography and cryo-electron microscopy, to learn how SMO engages PKAcat at the atomic level, enabling precise manipulation of this interaction for therapeutic purposes. To carry out the proposed studies, we have assembled a team of experts in biochemical / cell biological mechanisms of Hh signal transduction (Myers), structure / biophysics of PKA (Taylor), human cellular and organoid retina models (Wahlin), and zebrafish eye development (Kwan). The knowledge gleaned from our work will be vital in the development of therapeutics for a range of debilitating eye disorders, as well as for production of specific ocular cell types in regenerative medicine. It will also foster the development of drugs th...

Key facts

NIH application ID
10882991
Project number
1R01EY035377-01A1
Recipient
UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH
Principal Investigator
Kristen M Kwan
Activity code
R01
Funding institute
NIH
Fiscal year
2024
Award amount
$714,141
Award type
1
Project period
2024-07-01 → 2028-06-30